Table of Contents

• 1.   Research Methodology
  • 1 Introduction
      1. Objectives of the Study
      2. Market Definition
       2.1 . Markets Covered
       2.2 . Years Considered for the Study
      3. Currency
      4. Limitations
      5. Stakeholders
      2.1 . Research Approach
      2.2 . Research Data
       2.2.1 . Secondary Sources
        2.2.1. Key Data from Secondary Sources
       2.2.2 . Primary Sources
        2.2.2.1 . Key Data from Primary Sources
        2.2.2.2 . Breakdown of Primary Interviews
      2.3 . Market Size Estimation
      2.4 . Market Breakdown and Data Triangulation
      2.5 . Research Assumptions
    3 Executive Summary
      3.1. Market Outlook
      3.2. Segment Outlook
      3.3. Competitive Insights
    
• 2.   Global Therapeutic Stent Market Overview
  •   4.1. Introduction
       4.1.1. Industry Evolution / Developments
      4.2. Overview
      4.3. Market Dynamics
       4.3.1. Drivers
       4.3.2. Restraints
       4.3.3. Opportunities
      4.4. Market Analysis and Forecast, 2020–2027
       4.4.1. Market Value (US$ Mn) Projections
      4.5. Porter’s Five Force Analysis
    
• 3.   Global Therapeutic Stent Market Analysis and Forecast, by Product Type
  •   5.1. Introduction
    Definition
      5.2. Key Findings / Developments
    
• 4.   Global Therapeutic Stent Market Analysis and Forecast, by Application
  •   6.1. Introduction
    Definition
      6.2. Key Findings / Developments
    
• 5.   Global Therapeutic Stent Market Analysis and Forecast, by Region
  •   7.1. Key Findings
      7.2. Market Value Forecast, by Region
       7.2.1. North America
       7.2.2. Europe
       7.2.3. Asia Pacific
       7.2.4. Rest of the world
    8 Competition Landscape
      8.1. Market Player – Competition Matrix (By Tier and Size of companies)
      8.2. Market Share Analysis by Company (2020)
      8.3. Market Footprint Analysis
       8.3.1. By Region
      8.4. Competitive Business Strategies
    9 Company Profiles
      9.1.
    Abbott Laboratories
       9.1.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.1.2. Product Portfolio
       9.1.3. SWOT Analysis
       9.1.4. Financial Overview
       9.1.5. Strategic Overview
      9.2.
    
• 6.  B.BRAUN MELSUNGEN AG
  •    9.2.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.2.2. Product Portfolio
       9.2.3. SWOT Analysis
       9.2.4. Financial Overview
       9.2.5. Strategic Overview
      9.3. BIOTRONIK SE
       9.3.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.3.2. Product Portfolio
       9.3.3. SWOT Analysis
       9.3.4. Financial Overview
       9.3.5. Strategic Overview
       9.4. BOSTON SCIENTIFIC.
       9.4.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.4.2. Product Portfolio
       9.4.3. SWOT Analysis
       9.4.4. Financial Overview
       9.4.5. Strategic Overview
        9.5. C.R. BARD
       9.5.1. Company Overview (HQ, Business Segments, Employee Strength)
       9.5.2. Product Portfolio
       9.5.3. SWOT Analysis
       9.5.4. Financial Overview
       9.5.5. Strategic Overview
    10 Research Finding and Conclusion
    11 Research Methodology
    12 Research Data Source